{"info": {"address1": "1000 Alfred Nobel Drive", "city": "Hercules", "state": "CA", "zip": "94547", "country": "United States", "phone": "510 724 7000", "fax": "510 741 5817", "website": "https://www.bio-rad.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "fullTimeEmployees": 8200, "companyOfficers": [{"maxAge": 1, "name": "Mr. Norman D. Schwartz", "age": 72, "title": "Chairman, CEO & Pres", "yearBorn": 1950, "fiscalYear": 2022, "totalPay": 2129637, "exercisedValue": 15227430, "unexercisedValue": 34999260}, {"maxAge": 1, "name": "Mr. Ilan  Daskal", "age": 56, "title": "Exec. VP & CFO", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 952434, "exercisedValue": 0, "unexercisedValue": 77455}, {"maxAge": 1, "name": "Dr. Andrew J. Last Ph.D.", "age": 62, "title": "Exec. VP & COO", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 1116742, "exercisedValue": 0, "unexercisedValue": 121250}, {"maxAge": 1, "name": "Dr. Simon  May", "title": "Exec. VP & Pres of the Life Science Group", "fiscalYear": 2022, "totalPay": 787764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dara  Grantham Wright", "age": 46, "title": "Exec. VP & Pres of Clinical Diagnostics Group", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": 849528, "exercisedValue": 0, "unexercisedValue": 80722}, {"maxAge": 1, "name": "Mr. Ajit  Ramalingam", "age": 49, "title": "Sr. VP & Chief Accounting Officer", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yong  Chung", "title": "VP of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy S. Ernst", "age": 62, "title": "Exec. VP, Gen. Counsel & Sec.", "yearBorn": 1960, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Colleen  Corey", "title": "Sr. VP of Global HR", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Crowley", "age": 60, "title": "Exec. VP of Global Commercial Operations", "yearBorn": 1962, "fiscalYear": 2021, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1680307200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 481.51, "open": 481.55, "dayLow": 475.44, "dayHigh": 481.55, "regularMarketPreviousClose": 481.51, "regularMarketOpen": 481.55, "regularMarketDayLow": 475.44, "regularMarketDayHigh": 481.55, "payoutRatio": 0.0, "beta": 0.908304, "forwardPE": 26.45831, "volume": 94591, "regularMarketVolume": 94591, "averageVolume": 161286, "averageVolume10days": 104490, "averageDailyVolume10Day": 104490, "bid": 0.0, "ask": 0.0, "bidSize": 800, "askSize": 800, "marketCap": 14104218624, "fiftyTwoWeekLow": 344.63, "fiftyTwoWeekHigh": 574.8, "priceToSalesTrailing12Months": 5.0331783, "fiftyDayAverage": 475.707, "twoHundredDayAverage": 457.81055, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 13781186560, "profitMargins": -1.29451, "floatShares": 21097303, "sharesOutstanding": 24521600, "sharesShort": 265151, "sharesShortPriorMonth": 279007, "sharesShortPreviousMonthDate": 1677542400, "dateShortInterest": 1680220800, "sharesPercentSharesOut": 0.009, "heldPercentInsiders": 0.14527, "heldPercentInstitutions": 0.80522, "shortRatio": 1.48, "shortPercentOfFloat": 0.0125, "impliedSharesOutstanding": 0, "bookValue": 324.887, "priceToBook": 1.4748513, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": -3627535104, "trailingEps": -120.15, "forwardEps": 18.11, "pegRatio": 1.68, "lastSplitFactor": "2:1", "lastSplitDate": 1015545600, "enterpriseToRevenue": 4.918, "enterpriseToEbitda": 22.078, "52WeekChange": -0.1474173, "SandP52WeekChange": -0.06829989, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "BIO", "underlyingSymbol": "BIO", "shortName": "Bio-Rad Laboratories, Inc.", "longName": "Bio-Rad Laboratories, Inc.", "firstTradeDateEpochUtc": 320509800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6cebea0a-fe88-3cb6-af78-b738eb7ab8a1", "messageBoardId": "finmb_255743", "gmtOffSetMilliseconds": -14400000, "currentPrice": 479.16, "targetHighPrice": 680.0, "targetLowPrice": 550.0, "targetMeanPrice": 617.4, "targetMedianPrice": 615.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 1790672000, "totalCashPerShare": 60.504, "ebitda": 624216000, "totalDebt": 1388114048, "quickRatio": 4.039, "currentRatio": 5.553, "totalRevenue": 2802248960, "debtToEquity": 14.437, "revenuePerShare": 94.083, "returnOnAssets": 0.01944, "returnOnEquity": -0.31137, "grossProfits": 1568430000, "freeCashflow": 45594248, "operatingCashflow": 194400000, "revenueGrowth": -0.003, "grossMargins": 0.5597, "ebitdaMargins": 0.22275999, "operatingMargins": 0.17376, "financialCurrency": "USD", "trailingPegRatio": null}, "news": [{"uuid": "248ef213-17b0-39ba-8f8f-e81eff4b79d3", "title": "Bio-Rad Laboratories (BIO) Stock Sinks As Market Gains: What You Should Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bio-rad-laboratories-bio-stock-221510242.html", "providerPublishTime": 1681856110, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yp6cNdqNPYrEVdq5QZT5dA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIO-B"]}, {"uuid": "d09da82d-1a58-385b-954b-97a4699cbd4f", "title": "What's in Store for Thermo Fisher (TMO) in Q1 Earnings?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/whats-store-thermo-fisher-tmo-160204907.html", "providerPublishTime": 1681833724, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ZlehootNPPyHl08pJpk9NA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c71a79e42910967e6eba979803405e9b", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/u11LCHvJf80Ox_GgfwQR4Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/c71a79e42910967e6eba979803405e9b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TMO", "BIO-B"]}, {"uuid": "1c81529d-ed10-350d-919c-2e487e02da12", "title": "Align Technology (ALGN) to Post Q1 Earnings: What's in Store?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/align-technology-algn-post-q1-132301479.html", "providerPublishTime": 1681824181, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/tSYJcwmvH0UVClbkNhG6Iw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/8c9aa520cd383f468a783b3c3a59430b", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ev7afN0aLfCaexOtQR7gbQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/8c9aa520cd383f468a783b3c3a59430b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALGN", "DGX", "BIO-B"]}, {"uuid": "dff86868-72ed-3edc-899b-8dc63e512db8", "title": "Those who invested in Bio-Rad Laboratories (NYSE:BIO) five years ago are up 84%", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/those-invested-bio-rad-laboratories-112835268.html", "providerPublishTime": 1681817315, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7Rlbn9Tsmh0.PwBJuKlOEw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIO-B"]}, {"uuid": "b3f6917e-04c9-3397-8d5c-7da6f33ba7f5", "title": "LabCorp (LH) to Report Q1 Earnings: What's in the Cards?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/labcorp-lh-report-q1-earnings-135201973.html", "providerPublishTime": 1681739521, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zqaM_nL6N3BC_FVBtYx70Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59170f8a3705c99a906d0ff8cd107176", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Mf5gbURv95ACNbXvQvljCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/59170f8a3705c99a906d0ff8cd107176", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["LH", "BIO-B"]}, {"uuid": "3995e96c-722e-371c-98bb-80582fe471f1", "title": "QuidelOrtho (QDEL) Soars 5.0%: Is Further Upside Left in the Stock?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/quidelortho-qdel-soars-5-0-132301176.html", "providerPublishTime": 1681737781, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zbxTngo3t9SYKBfvYguuEA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a3a911c33bf707aefe1171061894a8aa", "width": 900, "height": 633, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tijM83w5HLTFE4L5Ix2Rbg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a3a911c33bf707aefe1171061894a8aa", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIO-B"]}, {"uuid": "84061c9d-cdc3-3eb6-b1a7-cf97b1f71df8", "title": "Bio-Rad (BIO) Rises 6.5% Since Q4 Earnings: What's Driving It?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bio-rad-bio-rises-6-151603774.html", "providerPublishTime": 1681485363, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.cFExAtq.C.oud6sX39cog--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/cF4uSOGjkfWEvmk4.sKSBw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIO-B", "HOLX", "HSIC", "AVNS"]}, {"uuid": "10b85c1e-e390-306b-8e15-3be6bd9f6939", "title": "Is BioRad Laboratories (BIO) Stock Outpacing Its Medical Peers This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biorad-laboratories-bio-stock-outpacing-134001733.html", "providerPublishTime": 1681479601, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a", "width": 900, "height": 476, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pdW5wHTIEKqiEK3RrmtVaw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIO-B", "CRSP"]}]}